In Silico docking of piperazin analog for non-small cell lung cancer having mutations in EGFR, ALK, and BRAF proteins. J Rashid Latif Med Col [Internet]. 2022 Dec. 29 [cited 2025 Oct. 18];1(2). Available from: https://jrlmc.com.pk/journal/index.php/jrlmc/article/view/12